ENKORE Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments
- Coordinator
- Universidad Politecnica De Madrid, Spain
- Runs
- 1 January 2025 to 31 December 2028
- Status
- Running
- EU funding
- €7.7m
- Total cost
- €14.5m
- Partners
- 52 organisations in 15 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101166707
What the project is doing
In the project's own words, from its summary on CORDIS.
The healthcare sector is hindered by several barriers that hamper the application of circular economy principles (e.g. the safety restrictions of the domain limit the use of recycled materials due to the need of materials biocompatibility, and safety in products to be used in the human body). Led by a multidisciplinary consortium of 39 partners (plus 13 industry affiliates) from 15 EU countries plus UK and USA, ENKORE aim to tackle challenges and develop an ecoDesign framework that supports the development of safe and environmental compliant devices eco-responsible packaging, which minimize the environmental impact, reduce the carbon footprint, and maximize the use and preservation of resources.
The main goal is to connect the design of the medical devices packages with the end-of-life stage, thus the technologies that support circularity are taken into account at the medical device conception stage. ENKORE framework will be validated in 5 Reference Use Cases (RUCs), led by 5 different health regions that bring HPCs and policy maker, 3 large EU hospitals and the reference network for European Regional and Local Health Authorities (EUREGHA).
The project developments and RUCs are supported by several associations and NGOs, a packaging manufacturer and a group of SMEs and researchers, specialists in circularity, LCA, social sciences, environment, circularity, and materials. The validation of the framework shall provide evidence to work with policymakers, creating new or revised standards and create tangible/quantitative evidence. Policy making and regulatory engagement will be strongly performed.
The methods and tools comprise Environmental and Social Life Cycle Assessment (ELCA/SLCA), Circularity Calculator (CC) and Digital Product Passport (DPP) approaches, which could be adapted during the second stage of the proposal.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Politecnica De Madrid | Madrid | Spain | Coordinator |
| Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju | Sarajevo | Bosnia and Herzegovina | Participant |
| Baxter R and D Europe | Lessines | Belgium | Participant |
| European Regional and Local Health Authorities ASBL | Etterbeek | Belgium | Participant |
| Forum Des Patients Europeens | Bruxelles / Brussel | Belgium | Participant |
| Takeda Pharmaceuticals International AG | Glattpark | Switzerland | Participant |
| Udg Alliance | Lausanne | Switzerland | Associatedpartner |
| World Resources Forum Association | Winterthur | Switzerland | Associatedpartner |
| Boehringer Ingelheim Internationalgmbh | Ingelheim | Germany | Participant |
| Boehringer Ingelheim Pharma GmbH &co Kg | Ingelheim | Germany | Associatedpartner |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| Fresenius Medical Care Deutschland GmbH | Bad Homburg | Germany | Participant |
| Johnson & Johnson Medical GmbH | Norderstedt | Germany | Participant |
| Lilly Deutschland GmbH | Bad Homburg | Germany | Associatedpartner |
| Pfizer Manufacturing Deutschland GmbH mit Sitz Illertissen | Illertissen | Germany | Associatedpartner |
| Eli Lilly Danmark A/S | Herlev | Denmark | Associatedpartner |
| Novo Nordisk A/s | Bagsvaerd | Denmark | Participant |
| Enosi Asthenon Elladas | Athina | Greece | Participant |
| Idryma Technologias Kai Erevnas | Irakleio | Greece | Participant |
| Institoyto Bioiatrikis Texnologias | Patras | Greece | Participant |
| Tech Hive Labs Astiki Mi Kerdoskopiki Etaireia | Chalandri | Greece | Participant |
| Active Ageing Association | Paterna | Spain | Participant |
| Consorcio Mar Parc De Salut De Barcelona | Barcelona | Spain | Participant |
| Fundacion Universidad Francisco De Vitoria | Pozuelo De Alarcon | Spain | Participant |
| Happy Mondays Communication SL | Madrid | Spain | Participant |
| Medtronic Iberica SA | Madrid | Spain | Participant |
| Predictby Research and Consulting S.l. | Barcelona | Spain | Participant |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Sofradim Production Sasu | Trevoux | France | Third party |
| Sterimed Holding | Boulogne Billancourt | France | Participant |
| Pfizer Ireland Pharmaceuticals | Cork | Ireland | Associatedpartner |
| Agenzia Regionale per La Salute Ed Il Sociale | Bari | Italy | Participant |
| Fondazione Policlinico Universitario Campus Bio Medico | Roma | Italy | Participant |
| Multimed Engineers SRL | Parma | Italy | Participant |
| Osai Automation System SpA Societa' Benefit | Torino | Italy | Participant |
| Pfizer Italia s.r.l. | Latina | Italy | Associatedpartner |
| Universita Campus Bio Medico Di Roma | Roma | Italy | Participant |
| Dupont De Nemours (luxembourg) SARL | Luxembourg | Luxembourg | Participant |
| International Solid Waste Association | Rotterdam | Netherlands | Participant |
| Samenwerkende Topklinische Opleidingsziekenhuizen | Utrecht | Netherlands | Participant |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Politechnika Poznanska | Poznan | Poland | Participant |
| Uniwersytet Medyczny W Lodzi | Lodz | Poland | Participant |
| DePuy International Limited | Leeds | United Kingdom | Associatedpartner |
| Eli Lilly and Company Ltd | Basingstoke | United Kingdom | Associatedpartner |
| Pfizer Limited | Sandwich | United Kingdom | Associatedpartner |
| Pfizer R&D UK Limited | Sandwich | United Kingdom | Associatedpartner |
| Technovative Solutions Ltd | Manchester | United Kingdom | Associatedpartner |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Ridgefield | United States | Associatedpartner |
| Eli Lilly and Company | Indianapolis | United States | Participant |
| Johnson & Johnson Services, Inc. | New Brunswick | United States | Associatedpartner |
| Pfizer Inc | New York City | United States | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI